Ionic Silver Technology Found Safe and
Effective
CLEARWATER, Fla.--(BUSINESS
WIRE)--Jan. 8, 2001--NVID International Inc. (Pink Sheets:NVID)
announced Monday the final results of a research project focused on
the effectiveness of Axenohl in a municipal drinking water system in
Costa Rica, featuring NVID's ionic silver-based microbial technology.
The 4-month study was conducted in the
municipal water system of Grecia, a community of 60,000 people just west
of San Jose, Costa Rica. EPA protocols were followed in the study
and all testing was performed as described in the Standard Methods for
the Examination of Water and Waste Water, 19th Edition, 1995. The
objective of the study was to determine the effectiveness of
Axenohl as a disinfecting agent in municipal
water system applications.
Prior to testing, the Grecia water
supply was contaminated with coliform bacteria and was not potable.
After treatment with 78 parts-per-billion (PPB) of Axenohl concentrate,
the fecal coliforms went from greater than 200 CFU/100ml to zero in
a period of 10 days. No other disinfectants or chemicals (including
chlorine) were used in conjunction with Axenohl during the testing
period. All water samples taken downstream had less than 50 PPB
Axenohl, which falls within the current EPA and European water treatment
guidelines for the presence of silver. Additionally, Axenohl proved to
control and reduce the presence and growth of biofilm in the piping distribution network. The community of Grecia intends to
continue the usage of Axenohl in its water supply network.
The data from this study will be
submitted to JAMA (Journal of the American Medical Association) and WHO
(World Health Organization) for peer review, and ultimately White
Paper publication. The project demonstrates the effectiveness and
potential of Axenohl as a replacement for traditional water treatment
agents.
Under a license agreement from NVID,
Innovative Medical Services (Nasdaq:PURE) and Sistecam S.A. teamed
together under the direction of Andrew Arata, inventor of record for
Axenohl, to implement the costly and time consuming Grecia drinking
water project in Costa Rica.
"The Grecia test results are one
more example that prove NVID's aqueous antimicrobial ionic silver
technology can realistically be viewed as a breakthrough
disinfectant," stated David J. Larson, president NVID
International. "Axenohl can effectively compete with
traditional water treatment disinfectants without creating any
known disinfection by-products, such as trihalomethanes (THM), which
have been proven to be carcinogenic."
Axenohl is NVID's non-toxic
antibacterial technology that uses the biocidal properties of
stabilized ionic silver to kill bacteria, viruses and fungi. Axenohl
does not include the use of traditional disinfectants such as quaternary ammonium
salts, phenols, glutaraldehyde, chlorine or bromine compounds. The
Axenohl formulations have been designed to compete, and/or replace
these products while eliminating the associated environmental hazards.
Additionally, the technology may prove to be revolutionary in the
healthcare market for treatment of disease, including human and
animal infections and wounds. The disinfection efficacy of Axenohl has been will documented by independent
testing laboratories. Axenohl eliminates the following test
organism strains all within one minute and 99.9999% efficacy.
Pseudomonas aeruginosa ATCC 15442
Staphylococcus aureus ATCC 6538
Salmonella cholerasuis ATCC 10708
E.Coli ATCC 0157:H7
Listeria monocytogenes ATCC 11543
Enterococcus faecium ATCC 11543
Rhinovirus (common colds)
Rotavirus (infectious diarrhea)
Vancomycin-resistant-enterococci (VRE) Antibiotic-resistant bacteria
Target markets include: hospital and
nursing home water systems, point-of-use/point-of-entry; municipal,
commercial and residential drinking water, FDA compliant consumer products,
pools and spas, cisterns/wells, veterinary, horticulture,
agriculture and food processing applications.
About NVID International Inc.
NVID International Inc., based in
Clearwater, manufactures and markets patented and patent-pending
proprietary ionization disinfection technologies that substantially
reduce or replace traditional disinfectants such as chlorine or
bromine.
